Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Renal Failure: full-pipeline trial registry
4 of 12 indexed Renal Failure trials are currently recruiting.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 4 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Renal Failure: 12 US clinical trials tracked, 4 recruiting.
Renal Failure is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Veloxis Pharmaceuticals, running 2 of these trials.
Enrollment posture brief
Registry condition renal-failure
OPEN 4 | RECR 33% | LATE 3 | EARLY 3 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Renal Failure lists 4 open slots (33% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Renal Failure on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Renal Failure is recruiting below its size-band peers.
4 of 12 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Renal Failure research.
Veloxis Pharmaceuticals accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.
-
Most Renal Failure trials plan to enrol fewer than 100 people.
Median target enrolment is 50 among the 12 trials that report a genuine target (sentinel values excluded). 8 of those (66.7%) plan for fewer than 100 participants.
-
Renal Failure research is mostly interventional.
10 interventional and 2 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
VenoStent
NCT06001827
Prevent Cardiac Surgery Associated AKI Trial
George Washington University
NCT06620523
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
Augusta University
NCT06142396
Post-Filter Hematocrit
Gwyndolyn M. Radford
NCT07293936
Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
Massachusetts General Hospital
NCT04540380
Improving Patient Prioritization During Hospital-homecare Transition
Columbia University
NCT04136951
Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Veloxis Pharmaceuticals
NCT00817206
Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary Hyperparathyroidism
Genzyme, a Sanofi Company
NCT00123461
Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
Veloxis Pharmaceuticals
NCT01962922
Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure
Vanderbilt University Medical Center
NCT02128802
Pharmacokinetics of Antiepileptics in Patients on CRRT
University of Maryland, Baltimore
NCT03632915
Daptomycin Study - Collection of Pharmacokinetic Samples in Patients With Renal Failure
University of Pittsburgh
NCT00573898
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Renal Failure records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Renal Failure trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Renal Failure page
12 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Renal Failure trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Veloxis Pharmaceuticals sponsors the most Renal Failure trials on record, review their full trial history before evaluating a specific study. See Veloxis Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Renal Failure condition card totals 12 registered trials; most-linked intervention LCP-Tacro; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.